BSAN:NEOBanco Santander S.A. Shs Sponsored Canadian Depository Receipt Hedged Reg S Analysis
Data as of 2026-05-20 - not real-time
CA$17.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Santander’s CAD‑hedged CDR is trading just above its 20‑day moving average and comfortably above the 50‑day and 200‑day averages, indicating a short‑term bullish bias. However, the MACD histogram has turned negative and the signal line is bearish, while volume has been on a downward trend, suggesting weakening momentum.
Fundamentally, the stock carries a very high price‑to‑earnings multiple relative to its regional banking peers, yet a discounted cash‑flow model places intrinsic value well above the current price, implying a potential upside. The recent earnings call highlighted a record first‑quarter profit with revenue growth and cost reductions, supporting the earnings narrative despite the modest revenue decline year‑over‑year.
Fundamentally, the stock carries a very high price‑to‑earnings multiple relative to its regional banking peers, yet a discounted cash‑flow model places intrinsic value well above the current price, implying a potential upside. The recent earnings call highlighted a record first‑quarter profit with revenue growth and cost reductions, supporting the earnings narrative despite the modest revenue decline year‑over‑year.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hugging recent support while staying above short‑term moving averages
- Bearish MACD signal and declining volume indicating fading momentum
- Recent earnings beat supporting near‑term confidence
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF‑derived fair value materially above current market price
- Strong operating margins and solid return on equity
- Record first‑quarter profit and cost‑efficiency improvements
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High valuation multiples relative to peers may limit upside
- Stable banking franchise with diversified revenue streams
- Exposure to European regulatory environment and macro‑economic cycles
Key Metrics & Analysis
Financial Health
Revenue Growth-0.50%
Profit Margin25.87%
P/E Ratio40.5
ROE13.33%
ROA0.79%
P/B Ratio2.5
Op. Cash FlowCA$4.6B
Industry P/E16.6
Technical Analysis
TrendBullish
RSI52.6
SupportCA$16.18
ResistanceCA$17.34
MA 20CA$17.05
MA 50CA$16.52
MA 200CA$15.54
MACDBearish
VolumeDecreasing
Fear & Greed Index89.93
Valuation
Fair ValueCA$23.34
GradeFair
TypeGrowth
Risk Assessment
Beta0.67
Volatility21.72%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.